Piper Sandler NY IB - Best Groups/Exit Opps?

Hey everyone, curious what people think about group placement at Piper Sandler NY. Groups in the office are HC, FIG, Chemicals, Consumer, and RX.

Piper's FIG desk (legacy Sandler O'Neill) has a strong reputation on the street — but does it silo you too hard? Exits seem concentrated in FIG-specific roles rather than generalist MM/UMM PE

Healthcare seems like the other obvious pick but is PS specifically strong enough there to crack top PE shops, or is the exit ceiling capped at MM?

Also curious about Restructuring - RX experience generally travels well to distressed/credit, but is PS's platform strong enough there to matter relative to the other groups?

Which group would you prioritize and why?

3 Comments
 

Based on the most helpful WSO content, here's a breakdown of Piper Sandler's NY IB groups and their exit opportunities:

  1. FIG (Financial Institutions Group):

    • The FIG desk, inherited from Sandler O'Neill, is highly regarded and has a strong reputation on the street.
    • However, exits tend to be more specialized, often leading to FIG-specific roles rather than generalist positions in MM/UMM PE. If you're passionate about FIG or see yourself in FIG-focused buy-side roles, this is a solid choice. Otherwise, it might feel limiting.
  2. Healthcare (HC):

    • Healthcare is considered one of Piper Sandler's strongest focuses across the firm.
    • Analysts in this group have been able to secure exits into MM and occasionally UMM PE, but the ceiling for top-tier PE shops might be capped compared to elite boutiques or bulge brackets.
    • If you're looking for a group with broader exit opportunities and a strong deal flow, this is a great pick.
  3. Chemicals:

    • The Chemicals group (legacy Valence Group) is one of the best on the street for this sector.
    • It handles several multi-billion-dollar deals annually and has solid PE exits, making it a standout group at Piper Sandler.
    • If you're interested in a niche but highly respected sector, this group is worth prioritizing.
  4. Restructuring (RX):

    • RX experience generally travels well to distressed/credit buy-side roles.
    • However, Piper Sandler's RX platform doesn't seem to have the same strength or reputation as its Chemicals or Healthcare groups. While RX experience is valuable, the platform's relative weakness might limit its impact compared to other groups.
  5. Consumer:

    • This group hasn't been highlighted as a standout at Piper Sandler, and there isn't much information suggesting it offers exceptional exit opportunities.

Recommendation:

  • Top Pick: Chemicals, for its strong reputation, high-profile deals, and solid PE exits.
  • Second Choice: Healthcare, for its broader exit opportunities and strong focus within the firm.
  • Consideration: FIG, if you're interested in specialized FIG roles and are okay with a narrower exit path.
  • Avoid: RX and Consumer, unless you have a specific interest in those areas, as they don't seem to offer the same level of opportunities.

Choose based on your career goals and the type of exit opportunities you prioritize!

Sources: Piper Sandler up and coming MM??, Piper Sandler up and coming MM??, Exit opps: I've crunched the previous work experience of 390 PE Associates.., EB Comparisons, Accept mid-tier BB Offer or continue recruiting?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Et aut nam soluta velit voluptatem nesciunt a. Eveniet earum officiis praesentium et. Minus fuga est ut quia.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”